PATH vs. DOCU, ESTC, DUOL, GEN, PCOR, CFLT, SPSC, KVYO, BRZE, and CXM
Should you be buying UiPath stock or one of its competitors? The main competitors of UiPath include DocuSign (DOCU), Elastic (ESTC), Duolingo (DUOL), Gen Digital (GEN), Procore Technologies (PCOR), Confluent (CFLT), SPS Commerce (SPSC), Klaviyo (KVYO), Braze (BRZE), and Sprinklr (CXM). These companies are all part of the "prepackaged software" industry.
DocuSign (NASDAQ:DOCU) and UiPath (NYSE:PATH) are both large-cap business services companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, media sentiment, earnings, institutional ownership, profitability, community ranking, valuation, dividends and risk.
DocuSign has a beta of 0.88, suggesting that its stock price is 12% less volatile than the S&P 500. Comparatively, UiPath has a beta of 1.01, suggesting that its stock price is 1% more volatile than the S&P 500.
DocuSign has higher revenue and earnings than UiPath. UiPath is trading at a lower price-to-earnings ratio than DocuSign, indicating that it is currently the more affordable of the two stocks.
77.6% of DocuSign shares are held by institutional investors. Comparatively, 62.5% of UiPath shares are held by institutional investors. 1.7% of DocuSign shares are held by insiders. Comparatively, 31.0% of UiPath shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.
In the previous week, UiPath had 6 more articles in the media than DocuSign. MarketBeat recorded 19 mentions for UiPath and 13 mentions for DocuSign. DocuSign's average media sentiment score of 0.80 beat UiPath's score of 0.64 indicating that UiPath is being referred to more favorably in the news media.
DocuSign presently has a consensus price target of $60.25, suggesting a potential upside of 3.83%. UiPath has a consensus price target of $27.41, suggesting a potential upside of 42.62%. Given DocuSign's stronger consensus rating and higher probable upside, analysts plainly believe UiPath is more favorable than DocuSign.
DocuSign has a net margin of 2.68% compared to DocuSign's net margin of -6.87%. UiPath's return on equity of 13.91% beat DocuSign's return on equity.
DocuSign received 287 more outperform votes than UiPath when rated by MarketBeat users. Likewise, 59.71% of users gave DocuSign an outperform vote while only 45.13% of users gave UiPath an outperform vote.
Summary
DocuSign beats UiPath on 10 of the 18 factors compared between the two stocks.
Get UiPath News Delivered to You Automatically
Sign up to receive the latest news and ratings for PATH and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding PATH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
